Prophylaxis

/Tag:Prophylaxis

Abstract Number: 395

RIFAXIMIN AND LACTULOSE COMBINATION THERAPY VERSUS LACTULOSE ALONE FOR PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS

Background: Rifaximin 550 mg tablets is a nonsystemic antibiotic indicated for reducing the risk of overt hepatic encephalopathy (HE) recurrence in adults and may be used in combination with lactulose. Practice guidelines state that rifaximin [...]

By | 2019-03-11T14:25:21+00:00 March 11th, 2019|Hospital Medicine 2019, Research, Transitions of Care|Comments Off on RIFAXIMIN AND LACTULOSE COMBINATION THERAPY VERSUS LACTULOSE ALONE FOR PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS

HM2017 Abstract Number: 229

PADUA TO IMPROVE: MATCHING VTE RISK STRATIFICAITON TOOL TO THE EHR

Background: Risk stratifying patients for potential development of hospital-related venous thromboembolism (VTE) is an important aspect of inpatient safety and is recommended by current guidelines.  Many risk stratification tools are cumbersome and require significant time [...]

By | 2017-04-20T17:42:38+00:00 April 20th, 2017|Innovations Abstracts, Technology in Hospital Medicine|Comments Off on PADUA TO IMPROVE: MATCHING VTE RISK STRATIFICAITON TOOL TO THE EHR

HM2016 Abstract Number: 119

Low Risk of Venous Thromboembolism in Hospitalized Stroke Patients

Background: Guidelines and quality performance measures recommend venous thromboembolism (VTE) prophylaxis in patients hospitalized with stroke if they have paralysis or are confined to bed and also recommend that all hospitalized medical patients have VTE [...]

By | 2016-02-01T08:00:34+00:00 February 1st, 2016|Outcomes Research, Research Abstracts|Comments Off on Low Risk of Venous Thromboembolism in Hospitalized Stroke Patients